DrugPatentWatch Database Preview
Bausch And Lomb Company Profile
What is the competitive landscape for BAUSCH AND LOMB, and what generic alternatives to BAUSCH AND LOMB drugs are available?
There are twenty-seven US patents protecting BAUSCH AND LOMB drugs.
There are two hundred and twenty-nine patent family members on BAUSCH AND LOMB drugs in forty-two countries and forty-nine supplementary protection certificates in eleven countries.
Summary for Bausch And Lomb
| International Patents: | 229 |
| US Patents: | 27 |
| Tradenames: | 66 |
| Ingredients: | 54 |
| NDAs: | 77 |
Drugs and US Patents for Bausch And Lomb
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb | PROLENSA | bromfenac sodium | SOLUTION/DROPS;OPHTHALMIC | 203168-001 | Apr 5, 2013 | RX | Yes | Yes | 8,871,813 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Bausch And Lomb | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 090037-001 | Jul 14, 2009 | AT | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Bausch And Lomb | CROLOM | cromolyn sodium | SOLUTION/DROPS;OPHTHALMIC | 074443-001 | Jan 30, 1995 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Bausch And Lomb | DEXASPORIN | dexamethasone; neomycin sulfate; polymyxin b sulfate | SUSPENSION/DROPS;OPHTHALMIC | 064135-001 | Sep 13, 1995 | AT | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Bausch And Lomb
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch And Lomb | ALREX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020803-001 | Mar 9, 1998 | 5,540,930*PED | ➤ Sign Up |
| Bausch And Lomb | ZYLET | loteprednol etabonate; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 050804-001 | Dec 14, 2004 | 5,540,930*PED | ➤ Sign Up |
| Bausch And Lomb | ALREX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020803-001 | Mar 9, 1998 | 5,747,061*PED | ➤ Sign Up |
| Bausch And Lomb | VITRASERT | ganciclovir | IMPLANT;IMPLANTATION | 020569-001 | Mar 4, 1996 | 5,378,475 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for BAUSCH AND LOMB drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Ophthalmic Solution | 0.5% | ➤ Subscribe | 2012-10-19 |
| ➤ Subscribe | Ophthalmic Solution | 0.07% | ➤ Subscribe | 2013-07-26 |
| ➤ Subscribe | Ophthalmic Solution | 1.5% | ➤ Subscribe | 2013-09-09 |
Non-Orange Book US Patents for Bausch And Lomb
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 8,765,758 | Compositions and methods for eye whitening | ➤ Sign Up |
| 8,580,787 | Compositions and methods for reducing activation of alpha-1 receptors | ➤ Sign Up |
| 7,749,970 | Topical treatment of prevention of ocular infections | ➤ Sign Up |
| 6,239,113 | Topical treatment or prevention of ocular infections | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Bausch And Lomb Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Australia | 2004313688 | ➤ Sign Up |
| Tunisia | SN06210 | ➤ Sign Up |
| European Patent Office | 2320911 | ➤ Sign Up |
| Cyprus | 1117417 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Bausch And Lomb Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2015000021 | Germany | ➤ Sign Up | PRODUCT NAME: TOBRAMYCIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/10/652/001-003 20110720 |
| C/GB02/027 | United Kingdom | ➤ Sign Up | PRODUCT NAME: 2-(2-AMINO-1,6-DIHYDRO-6-OXO-PURIN-9-YL)-METHOXY-3-HYDROXY-1-PROPANYL-L-VALINATE HYDROCHLORIDE (VALGANCICLOVIR HYDROCHLORIDE); REGISTERED: NL RVG 25992 20010920; UK PL 00031/0599 20020425 |
| 00494 | Netherlands | ➤ Sign Up | PRODUCT NAME: BROMFENAC, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF HYDRAAT; REGISTRATION NO/DATE: EU/1/11/692/001 20110518 |
| /1997 | Austria | ➤ Sign Up | PRODUCT NAME: LATANOPROST UND SEINE THERAPEUTISCH AKTIVEN UND PHYSIOLOGISCH ANNEHMBAREN DERIVATE; NAT. REGISTRATION NO/DATE: 1-22019 19970627; FIRST REGISTRATION: SE 12716 19960718 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
